CVS Health Corporation
CVS
$65.51
$0.630.97%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 1.02B | 1.78B | 1.64B | 87.00M | 1.77B |
Total Depreciation and Amortization | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 14.00M | 196.00M | -537.00M | 386.00M | 7.00M |
Change in Net Operating Assets | -309.00M | 1.43B | -394.00M | -2.38B | 161.00M |
Cash from Operations | 1.90B | 4.56B | 1.86B | -745.00M | 3.09B |
Capital Expenditure | -607.00M | -743.00M | -768.00M | -670.00M | -638.00M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -119.00M | -20.00M | -10.00M | -12.00M | -48.00M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -298.00M | 1.00M | 231.00M | -2.67B | -939.00M |
Cash from Investing | -1.02B | -762.00M | -547.00M | -3.35B | -1.63B |
Total Debt Issued | 921.00M | -- | 4.27B | 600.00M | 2.44B |
Total Debt Repaid | 840.00M | -1.60B | -3.07B | -1.47B | -219.00M |
Issuance of Common Stock | 47.00M | 144.00M | 19.00M | 114.00M | 25.00M |
Repurchase of Common Stock | -114.00M | -11.00M | -4.00M | -4.00M | -142.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -866.00M | -840.00M | -838.00M | -837.00M | -858.00M |
Other Financing Activities | -22.00M | -23.00M | 48.00M | 8.00M | 3.00M |
Cash from Financing | 806.00M | -2.33B | 431.00M | -1.59B | 1.25B |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1.68B | 1.46B | 1.74B | -5.68B | 2.71B |